Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer

被引:79
|
作者
Hershman, Dawn L. [1 ,2 ,4 ,5 ]
Buono, Donna [4 ,5 ]
McBride, Russell B. [4 ,5 ]
Tsai, Wei Yann [1 ,6 ]
Joseph, Kathy Ann [1 ,3 ]
Grann, Victor R. [1 ,2 ,4 ,5 ]
Jacobson, Judith S. [1 ,4 ,5 ]
机构
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Mailman Sch Publ Hlth, New York, NY 10032 USA
[2] Columbia Univ, Dept Med, Mailman Sch Publ Hlth, New York, NY USA
[3] Columbia Univ, Dept Surg, Mailman Sch Publ Hlth, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Mailman Sch Publ Hlth, New York, NY USA
[5] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA
[6] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA
来源
关键词
D O I
10.1093/jnci/djm320
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adjuvant radiotherapy following breast conservation surgery (BCS) is considered to be an indicator of quality of care for the majority of women with breast cancer, but many women do not receive adjuvant radiotherapy. We investigated the association of surgeon-related factors with receipt of adjuvant radiotherapy after BCS. Methods We used the linked Surveillance, Epidemiology and End Results (SEER)-Medicare database to identify women aged 65 years or older with stage I/II breast cancer who were diagnosed between 1991 and 2002 and underwent BCS. We collected demographic and clinical data from SEER and treatment information from Medicare claims data. The American Medical Association Masterfile was used to obtain information on surgeons' characteristics, including sex, medical school location (United States or elsewhere), and type of degree (MD or Doctorate in Osteopathic Medicine [DO]). The associations of patient (age, race, rural vs urban residence, comorbidities, marital status), tumor (hormone receptor status, grade, stage), and surgeon-related factors with receipt of adjuvant radiotherapy were analyzed using Generalized Estimating Equations to control for clustering. All statistical tests were two-sided. Results Of 29 760 women in our sample, 22 207 (75%) received radiotherapy. Patients who received adjuvant radiotherapy were younger, had fewer comorbidities, and were more likely to be white, married, from an urban area, and diagnosed in a later year compared with those who did not. They were also more likely to have a surgeon who was female (79% vs 73%), had an MD degree ( 75% vs 68%), or was US trained ( 75% vs 70%). The multivariable analysis confirmed the association of radiotherapy with having a surgeon who was female (odds ratio [OR] = 1.13; 95% confidence interval [CI] = 1.06 to 1.27), had an MD degree (OR = 1.55; 95% CI = 1.24 to 1.91), was US trained ( OR = 1.12; 95% CI = 1.01 to 1.25), or had more than 15 patients (OR = 1.18; 95% CI = 1.10 to 1.28). Conclusions Surgeon characteristics were associated with patients' receipt of adjuvant radiotherapy after BCS after controlling for patient and tumor characteristics, although the individual effect sizes were small for surgeon sex, location of training, and type of medical degree. More research is warranted to confirm the associations to determine whether they reflect surgeon behavior, patient response, or physician-patient interactions.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 50 条
  • [21] Racial disparities in the timely receipt of adjuvant radiotherapy for head and neck cancer
    Chen, Allen M.
    Harris, Jeremy P.
    Tjoa, Tjoson
    Haidar, Yarah
    Armstrong, William B.
    ORAL ONCOLOGY, 2023, 147
  • [22] Surgeon Characteristics and Use of Breast Conservation Surgery in Women With Early Stage Breast Cancer
    Hershman, Dawn L.
    Buono, Donna
    Jacobson, Judith S.
    McBride, Russell B.
    Tsai, Wei Yann
    Joseph, Kathie Ann
    Neugut, Alfred I.
    ANNALS OF SURGERY, 2009, 249 (05) : 828 - 833
  • [23] Adjuvant radiotherapy of women with breast cancer - Information, support and side-effects
    Sjovall, K.
    Strombeck, G.
    Lofgren, A.
    Bendahl, P-O
    Gunnars, B.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 147 - 153
  • [24] Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
    Ragaz, J
    Jackson, SM
    Le, N
    Plenderleith, IH
    Spinelli, JJ
    Basco, VE
    Wilson, KS
    Knowling, MA
    Coppin, CML
    Paradis, M
    Coldman, AJ
    Olivotto, IA
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14): : 956 - 962
  • [25] Surgeon influence on receipt of contralateral prophylactic mastectomy for breast cancer.
    Katz, Steven J.
    Morrow, Monica
    Hawley, Sarah T.
    Jagsi, Reshma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Racial/Ethnic Differences in Adjuvant Trastuzumab Receipt for Women with Breast Cancer within the National Comprehensive Cancer Network.
    Freedman, R. A.
    Hughes, M. E.
    Ottesen, R. A.
    He, Y.
    Weeks, J. C.
    Wong, Y-N
    Theriault, R. L.
    Keating, N. L.
    CANCER RESEARCH, 2011, 71
  • [28] The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer
    Kolarova, Iveta
    Melichar, Bohuslav
    Sirak, Igor
    Vanasek, Jaroslav
    Petera, Jiri
    Horackova, Katerina
    Pohankova, Denisa
    Datelinka, Filip
    Sinkorova, Zuzana
    Vosmik, Milan
    CURRENT ONCOLOGY, 2024, 31 (03) : 1207 - 1220
  • [29] New tools in adjuvant breast cancer radiotherapy
    Belkacemi, Yazid
    Azria, David
    BULLETIN DU CANCER, 2007, 94 (04) : 389 - 397
  • [30] Cardiac morbidity of adjuvant radiotherapy for breast cancer
    Patt, DA
    Goodwin, JS
    Kuo, YF
    Freeman, JL
    Zhang, DD
    Buchholz, TA
    Hortobagyi, GN
    Giordano, SH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7475 - 7482